Search Results - "Gubareva, Larisa V"

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020 by Govorkova, Elena A., Takashita, Emi, Daniels, Rod S., Fujisaki, Seiichiro, Presser, Lance D., Patel, Mira C., Huang, Weijuan, Lackenby, Angie, Nguyen, Ha T., Pereyaslov, Dmitriy, Rattigan, Aine, Brown, Sook Kwan, Samaan, Magdi, Subbarao, Kanta, Wong, Sun, Wang, Dayan, Webby, Richard J., Yen, Hui-Ling, Zhang, Wenqing, Meijer, Adam, Gubareva, Larisa V.

“…Global analysis of the susceptibility of influenza viruses to neuraminidase (NA) inhibitors (NAIs) and the polymerase acidic (PA) inhibitor (PAI) baloxavir was…”
Get full text

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017–2018 by Takashita, Emi, Daniels, Rod S., Fujisaki, Seiichiro, Gregory, Vicki, Gubareva, Larisa V., Huang, Weiijuan, Hurt, Aeron C., Lackenby, Angie, Nguyen, Ha T., Pereyaslov, Dmitriy, Roe, Merryn, Samaan, Magdi, Subbarao, Kanta, Tse, Herman, Wang, Dayan, Yen, Hui-Ling, Zhang, Wenqing, Meijer, Adam

“…The global analysis of neuraminidase inhibitor (NAI) susceptibility of influenza viruses has been conducted since the 2012–13 period. In 2018 a novel…”
Get full text

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017 by Lackenby, Angie, Besselaar, Terry G., Daniels, Rod S., Fry, Alicia, Gregory, Vicki, Gubareva, Larisa V., Huang, Weijuan, Hurt, Aeron C., Leang, Sook-Kwan, Lee, Raphael T.C., Lo, Janice, Lollis, Lori, Maurer-Stroh, Sebastian, Odagiri, Takato, Pereyaslov, Dmitriy, Takashita, Emi, Wang, Dayan, Zhang, Wenqing, Meijer, Adam

“…A total of 13672 viruses, collected by World Health Organization recognised National Influenza Centres between May 2016 and May 2017, were assessed for…”
Get full text

Surveillance of Resistance to Adamantanes among Influenza A(H3N2) and A(H1N1) Viruses Isolated Worldwide by Deyde, Varough M., Xu, Xiyan, Bright, Rick A., Shaw, Michael, Smith, Catherine B., Zhang, Ye, Shu, Yuelong, Gubareva, Larisa V., Cox, Nancy J., Klimov, Alexander I.

“…Our previous reports demonstrated an alarming in crease in resistance to adamantanes among influenza A(H3N2) viruses isolated in 2001–2005. To continue…”
Get full text

Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives by Hurt, Aeron C, Dr, Chotpitayasunondh, Tawee, Prof, Cox, Nancy J, PhD, Daniels, Rod, PhD, Fry, Alicia M, MD, Gubareva, Larisa V, PhD, Hayden, Frederick G, Prof, Hui, David S, MD, Hungnes, Olav, PhD, Lackenby, Angie, PhD, Lim, Wilina, MD, Meijer, Adam, PhD, Penn, Charles, PhD, Tashiro, Masato, MD, Uyeki, Timothy M, MD, Zambon, Maria, Prof

“…Summary Influenza A H1N1 2009 virus caused the first pandemic in an era when neuraminidase inhibitor antiviral drugs were available in many countries. The…”
Get full text

Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group by Ison, Michael G., Hayden, Frederick G., Hay, Alan J., Gubareva, Larisa V., Govorkova, Elena A., Takashita, Emi, McKimm-Breschkin, Jennifer L.

“…It is more than 20 years since the neuraminidase inhibitors, oseltamivir and zanamivir were approved for the treatment and prevention of influenza. Guidelines…”
Get full text

Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009 by Shinde, Vivek, Bridges, Carolyn B, Uyeki, Timothy M, Shu, Bo, Balish, Amanda, Xu, Xiyan, Lindstrom, Stephen, Gubareva, Larisa V, Deyde, Varough, Garten, Rebecca J, Harris, Meghan, Gerber, Susan, Vagasky, Susan, Smith, Forrest, Pascoe, Neal, Martin, Karen, Dufficy, Deborah, Ritger, Kathy, Conover, Craig, Quinlisk, Patricia, Klimov, Alexander, Bresee, Joseph S, Finelli, Lyn

“…Influenza is known to infect several different hosts, including humans, birds, and pigs. The influenza genome is structured in a way that allows for rapid…”
Get full text

Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023-February 2024 by Patel, Mira C, Nguyen, Ha T, Pascua, Philippe Noriel Q, Gao, Rongyuan, Steel, John, Kondor, Rebecca J, Gubareva, Larisa V

“…Since May 2023, a novel combination of neuraminidase mutations, I223V + S247N, has been detected in influenza A(H1N1)pdm09 viruses collected in countries…”
Get full text

Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons by Gubareva, Larisa V, Mishin, Vasiliy P, Patel, Mira C, Chesnokov, Anton, Nguyen, Ha T, De La Cruz, Juan, Spencer, Sarah, Campbell, Angela P, Sinner, Mallory, Reid, Heather, Garten, Rebecca, Katz, Jackie M, Fry, Alicia M, Barnes, John, Wentworth, David E

“…The anti-influenza therapeutic baloxavir targets cap-dependent endonuclease activity of polymerase acidic (PA) protein. We monitored baloxavir susceptibility…”
Get full text

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016 by Gubareva, Larisa V., Besselaar, Terry G., Daniels, Rod S., Fry, Alicia, Gregory, Vicki, Huang, Weijuan, Hurt, Aeron C., Jorquera, Patricia A., Lackenby, Angie, Leang, Sook-Kwan, Lo, Janice, Pereyaslov, Dmitriy, Rebelo-de-Andrade, Helena, Siqueira, Marilda M., Takashita, Emi, Odagiri, Takato, Wang, Dayan, Zhang, Wenqing, Meijer, Adam

“…Four World Health Organization (WHO) Collaborating Centres for Reference and Research on Influenza and one WHO Collaborating Centre for the Surveillance,…”
Get full text

Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir by Mishin, Vasiliy P, Patel, Mira C, Chesnokov, Anton, De La Cruz, Juan, Nguyen, Ha T, Lollis, Lori, Hodges, Erin, Jang, Yunho, Barnes, John, Uyeki, Timothy, Davis, Charles T, Wentworth, David E, Gubareva, Larisa V

“…Baloxavir showed broad-spectrum in vitro replication inhibition of 4 types of influenza viruses (90% effective concentration range 1.2–98.3 nmol/L);…”
Get full text

Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods by Nguyen, Ha T, Fry, Alicia M, Gubareva, Larisa V

“…Infection with influenza viruses, including seasonal, avian and pandemic viruses, remains a worldwide public health problem. Although influenza virus infection…”
Get more information

Molecular Characterizations of Surface Proteins Hemagglutinin and Neuraminidase from Recent H5Nx Avian Influenza Viruses by Yang, Hua, Carney, Paul J, Mishin, Vasiliy P, Guo, Zhu, Chang, Jessie C, Wentworth, David E, Gubareva, Larisa V, Stevens, James

“…During 2014, a subclade 2.3.4.4 highly pathogenic avian influenza (HPAI) A(H5N8) virus caused poultry outbreaks around the world. In late 2014/early 2015, the…”
Get full text

Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008 by SHEU, Tiffany G, DEYDE, Varough M, OKOMO-ADHIAMBO, Margaret, GARTEN, Rebecca J, XIYAN XU, BRIGHT, Rick A, BUTLER, Eboneé N, WALLIS, Teresa R, KLIMOV, Alexander I, GUBAREVA, Larisa V

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Antiviral Susceptibility of Swine-Origin Influenza A Viruses Isolated from Humans, United States by Gao, Rongyuan, Pascua, Philippe Noriel Q, Chesnokov, Anton, Nguyen, Ha T, Uyeki, Timothy M, Mishin, Vasiliy P, Zanders, Natosha, Cui, Dan, Jang, Yunho, Jones, Joyce, La Cruz, Juan De, Di, Han, Davis, Charles Todd, Gubareva, Larisa V

“…Since 2013, a total of 167 human infections with swine-origin (variant) influenza A viruses of A(H1N1)v, A(H1N2)v, and A(H3N2)v subtypes have been reported in…”
Get full text

Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015 by Flannery, Brendan, Zimmerman, Richard K., Gubareva, Larisa V., Garten, Rebecca J., Chung, Jessie R., Nowalk, Mary Patricia, Jackson, Michael L., Jackson, Lisa A., Monto, Arnold S., Ohmit, Suzanne E., Belongia, Edward A., McLean, Huong Q., Gaglani, Manjusha, Piedra, Pedro A., Mishin, Vasiliy P., Chesnokov, Anton P., Spencer, Sarah, Thaker, Swathi N., Barnes, John R., Foust, Angie, Sessions, Wendy, Xu, Xiyan, Katz, Jacqueline, Fry, Alicia M.

“…Background. During the 2014-2015 US influenza season, expanded genetic characterization of circulating influenza A(H3N2) viruses was used to assess the impact…”
Get full text

R292K substitution and drug susceptibility of influenza A(H7N9) viruses by Sleeman, Katrina, Guo, Zhu, Barnes, John, Shaw, Michael, Stevens, James, Gubareva, Larisa V

“…Neuraminidase inhibitors are the only licensed antiviral medications available to treat avian influenza A(H7N9) virus infections in humans. According to a…”
Get full text

Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir by Patel, Mira C., Chesnokov, Anton, Jones, Joyce, Mishin, Vasiliy P., De La Cruz, Juan A., Nguyen, Ha T., Zanders, Natosha, Wentworth, David E., Davis, Todd C., Gubareva, Larisa V.

“…Pimodivir exerts an antiviral effect on the early stages of influenza A virus replication by inhibiting the cap-binding function of polymerase basic protein 2…”
Get full text

In Vitro Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses by SLEEMAN, Katrina, MISHIN, Vasiliy P, DEYDE, Varough M, FURUTA, Yousuke, KLIMOV, Alexander I, GUBAREVA, Larisa V

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses by Marjuki, Henju, Mishin, Vasiliy P, Chesnokov, Anton P, De La Cruz, Juan A, Davis, Charles T, Villanueva, Julie M, Fry, Alicia M, Gubareva, Larisa V

“…Human infections by avian influenza A(H7N9) virus entail substantial morbidity and mortality. Treatment of infected patients with the neuraminidase (NA)…”
Get full text